16:02 Dec 20
Divi's Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Divi's Laboratories Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
57/100
High Financial Strength
Valuation
14/100
Expensive Valuation
Technical
53/100
Technically Neutral
Strength
8
Weakness
9
Opportunity
1
Threats
1
1.55L
Market Cap (Cr)
84.54
PE Ratio
11.32
Price to Book Ratio
43.77
RSI
20.39 %
Net Profit Margin
Download Our App On:
